Pharma company AstraZeneca, which offers a program called Fit2Me that provides diet and lifestyle support for patients with diabetes, is now expanding its offering to include patients with risks for cardiovascular disease. The program is also now available via an iOS and Android app, which has only been the case since the end of June.
The customizable program focuses on four key areas of type 2...
Palo Alto, California-based MocaCare, which has developed a device that tracks cardiovascular health, raised $2 million in a round led by JDM Mobile Internet Solutions with participation from EMB International and Atom Health Corporation. This brings the company's total funding to $4 million to date.
The device, called MocaHeart, scans the user's fingertips to measure blood flow velocity and uses...
